Search

Your search keyword '"Huhtaniemi IT"' showing total 298 results

Search Constraints

Start Over You searched for: Author "Huhtaniemi IT" Remove constraint Author: "Huhtaniemi IT"
298 results on '"Huhtaniemi IT"'

Search Results

1. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

2. The Hypothalamic-Pituitary-Testicular Axis and Physical Frailty in Middle Aged and Older European Men: Results from the European Male Aging Study.

3. Genetic Determinants of Circulating Estrogen Levels and Evidence of a Causal Effect of Estradiol on Bone Density in Men

4. Evaluation of cognitive subdomains, 25-hydroxyvitamin D, and 1,25-dihydroxyvitamin D in the European Male Ageing Study

5. Glycemia but not the Metabolic Syndrome is Associated with Cognitive Decline: Findings from the European Male Ageing Study

6. Changes in prevalence of obesity and high waist circumference over four years across European regions: the European male ageing study (EMAS)

7. Changes in prevalence of obesity and high waist circumference over four years across European regions: the European male ageing study (EMAS)

8. Chronic widespread pain is associated with worsening frailty in European men

9. Chronic widespread pain is associated with worsening frailty in European men

10. Chronic widespread pain is associated with worsening frailty in European men

11. Lower bone turnover and relative bone deficits in men with metabolic syndrome: a matter of insulin sensitivity? The European Male Ageing Study

12. Frailty and bone health in European men

13. Low vitamin D and the risk of developing chronic widespread pain: Results from the European male ageing study

14. Association of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone with mortality among middle-aged and older European men

15. Low heel ultrasound parameters predict mortality in men: Results from the European Male Ageing Study (EMAS)

16. The effect of epitestosterone on gonadotrophin synthesis and secretion

19. Genetic determinants of serum testosterone concentrations in men

22. Worldwide frequency of a common genetic variant of luteinizing hormone: an international collaborative research

26. Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men.

27. Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants

28. Rising rural body-mass index is the main driver of the global obesity epidemic in adults

29. Insulin-like peptide 3 (INSL3) as an indicator of leydig cell insufficiency (LCI) in Middle-aged and older men with hypogonadism: reference range and threshold.

30. The Loss of Estradiol by Androgen Deprivation in Prostate Cancer Patients Shows the Importance of Estrogens in Males.

31. Evidence-based definition of hypoprolactinemia in European men aged 40-86 years: the European male ageing study.

32. Hyponatremia, hypernatremia and impairment of functional, psychological and sexual domains.

33. A tumor cell specific Zona Pellucida glycoprotein 3 RNA transcript encodes an intracellular cancer antigen.

34. Does testosterone influence the association between sleep and frailty in men: results from the European Male Aging Study.

35. Number of CAG repeats and mortality in middle aged and older men.

36. Sarcopenia-defining parameters, but not sarcopenia, are associated with cognitive domains in middle-aged and older European men.

37. Persistently expressed human chorionic gonadotropin induces premature luteinization and progressive alterations on the reproductive axis in female mice.

39. The Leydig cell biomarker INSL3 as a predictor of age-related morbidity: Findings from the EMAS cohort.

40. Association of age, hormonal, and lifestyle factors with the Leydig cell biomarker INSL3 in aging men from the European Male Aging Study cohort.

41. Reproductive hormone levels, androgen receptor CAG repeat length and their longitudinal relationships with decline in cognitive subdomains in men: The European Male Ageing Study.

42. Ageing male (part I): Pathophysiology and diagnosis of functional hypogonadism.

43. Impact of add-back FSH on human and mouse prostate following gonadotropin ablation by GnRH antagonist treatment.

44. Erectile dysfunction predicts mortality in middle-aged and older men independent of their sex steroid status.

45. Aging Men With Insufficient Vitamin D Have a Higher Mortality Risk: No Added Value of its Free Fractions or Active Form.

46. Inflammatory markers are associated with quality of life, physical activity, and gait speed but not sarcopenia in aged men (40-79 years).

47. The Roles of Luteinizing Hormone, Follicle-Stimulating Hormone and Testosterone in Spermatogenesis and Folliculogenesis Revisited.

48. Self-Reported Shorter Than Desired Ejaculation Latency and Related Distress-Prevalence and Clinical Correlates: Results From the European Male Ageing Study.

49. Follicle-stimulating hormone promotes growth of human prostate cancer cell line-derived tumor xenografts.

50. Mifepristone Treatment Promotes Testicular Leydig Cell Tumor Progression in Transgenic Mice.

Catalog

Books, media, physical & digital resources